Darifenacin hydrobromide is the hydrobromide salt of darifenacin. A selective antagonist for the M3 muscarinic acetylcholine receptor, that is mainly responsible for bladder muscle contractions, it is used in the management of urinary incontinence. Among its listed roles, it functions as a muscarinic antagonist. It includes a darifenacin. It is grouped under the following drug class(es): Overactive bladder agents. Its therapeutic use is listed as urological agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Enablex, Darilong and Emselex. Its PubChem CID is 444030.
Darifenacin hydrobromide
| CAS No | 133099-07-7 |
|---|---|
| Molecular Formula | C28H31BrN2O2 |
| Molecular Weight | 507.5 g/mol |
| Synonyms | 2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide;hydrobromide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Darifenacin hydrobromide is the hydrobromide salt of darifenacin. A selective antagonist for the M3 muscarinic acetylcholine receptor, that is mainly responsible for bladder muscle contractions, it is used in the management of urinary incontinence.
The listed CAS number is 133099-07-7.
The listed molecular formula is C28H31BrN2O2.
The listed molecular weight is 507.5 g/mol.
2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide;hydrobromide.
The source lists Enablex, Darilong and Emselex.